FindTrial
Sign In

A study to determine the UHRF1 gene expression in newly diagnosed breast cancer patients.

A prospective study to determine the UHRF1 mRNA and protein expression in newly diagnosed breast cancer patients. - APSDUMPENDBCP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/011710
Enrollment
50
Registered
2018-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Newly diagnosed breast cancer patients

Interventions

None listed

Sponsors

Kasturba Medical college Kasturba Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed cases of breast cancer. Patients scheduled for Modified Radical Mastectomy(MRM) or Breast Conservative Surgery(BCS).Patients who have not received Neo-adjuvant Chemotherapy(NACT) or Radiotherapy for treatment.

Exclusion criteria

Exclusion criteria: Patients who have received NACT or radiotherapy

Design outcomes

Primary

MeasureTime frame
The expression levels of the UHRF1 mRNA in the collected specimens will be measured.Timepoint: The expression levels of the UHRF1 mRNA in the collected specimens will be measured after 1 month—

Secondary

MeasureTime frame
The expression levels of the UHRF1 protein in the collected specimens will be measured.Timepoint: The expression levels of the UHRF1 protein in the collected specimens will be measured after 1 month.—

Countries

India

Contacts

Public ContactR Valli Sri Vidya

Manipal College of Pharmaceutical Sciences

mahadev.rao@manipal.edu8105706060

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026